Paralemmin Antikörper (Internal Region)
-
- Target Alle Paralemmin (PALM) Antikörper anzeigen
- Paralemmin (PALM)
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Paralemmin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Spezifität
- Reacts withParalemmin-1 from human, mouse and rat
- Aufreinigung
- Purified (protein A)
- Immunogen
- Synthetic peptide derived from internal part of human PALM protein.
- Top Product
- Discover our top product PALM Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- WB : 1/200 to 1/5 000 - IHC : 1/100 to 1/2 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- Paralemmin (PALM)
- Andere Bezeichnung
- Paralemmin-1 (PALM Produkte)
- Synonyme
- PALM antikoerper, palm antikoerper, zgc:110136 antikoerper, paralemmin antikoerper, paralemmin 1a antikoerper, paralemmin S homeolog antikoerper, PALM antikoerper, palm1a antikoerper, palm antikoerper, palm.S antikoerper, Palm antikoerper
- Hintergrund
- Belongs to the paralemmin family. Interacts with dopamine receptor DRD3
- UniProt
- O75781
- Pathways
- cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
-